2021
Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment
Paltiel AD, Zheng A, Schwartz JL. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment. Annals Of Internal Medicine 2021, 174: m20-7866. PMID: 33395345, PMCID: PMC7787166, DOI: 10.7326/m20-7866.Peer-Reviewed Original ResearchCommunicable Disease ControlCOVID-19COVID-19 VaccinesDisease ProgressionEfficiencyHumansPandemicsPneumonia, ViralSARS-CoV-2Time FactorsUnited StatesUnited States Food and Drug Administration
2011
Medical Device Innovation — Is “Better” Good Enough?
Suter LG, Paltiel AD, Rome BN, Solomon DH, Golovaty I, Gerlovin H, Katz JN, Losina E. Medical Device Innovation — Is “Better” Good Enough? New England Journal Of Medicine 2011, 365: 1464-1466. PMID: 22010911, PMCID: PMC3570242, DOI: 10.1056/nejmp1109285.Peer-Reviewed Original ResearchAgedComorbidityDevice ApprovalHumansKnee ProsthesisLife ExpectancyMiddle AgedModels, StatisticalProsthesis FailureReoperationRiskUnited StatesUnited States Food and Drug Administration
2009
Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing
Paltiel AD, Pollack HA. Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing. Medical Decision Making 2009, 30: 217-223. PMID: 19429837, PMCID: PMC2897074, DOI: 10.1177/0272989x09334420.Peer-Reviewed Original ResearchMeSH KeywordsDevice ApprovalHIV InfectionsHumansPredictive Value of TestsReagent Kits, DiagnosticUnited StatesUnited States Food and Drug Administration
2006
Rapid HIV testing at home: does it solve a problem or create one?
Walensky RP, Paltiel AD. Rapid HIV testing at home: does it solve a problem or create one? Annals Of Internal Medicine 2006, 145: 459-62. PMID: 16983134, DOI: 10.7326/0003-4819-145-6-200609190-00010.Peer-Reviewed Original ResearchMeSH KeywordsCosts and Cost AnalysisDevice ApprovalFalse Negative ReactionsFalse Positive ReactionsHIV InfectionsHIV-1HIV-2HumansReagent Kits, DiagnosticUnited StatesUnited States Food and Drug AdministrationConceptsRapid HIV testsHome HIV testHIV testHIV testingRapid home HIV testUnidentified HIV infectionRapid HIV testingHIV testing kitsHome HIV testingUndetectable diseaseFalse-negative resultsPublic health crisisHIV infectionHIV riskHIV detectionDrug AdministrationU.S. FoodHome testHIVHealth crisisHome useTesting kitsCareCautious perspectiveGreat need
1996
The FDA And Regulation Of Cost-Effectiveness Claims
Neumann P, Ƶinner D, Paltiel A. The FDA And Regulation Of Cost-Effectiveness Claims. Health Affairs 1996, 15: 54-71. PMID: 8854508, DOI: 10.1377/hlthaff.15.3.54.Peer-Reviewed Original ResearchCost-Benefit AnalysisDrug CostsDrug IndustryEconomics, PharmaceuticalHumansModels, EconomicPrivate SectorStreptokinaseTissue Plasminogen ActivatorUnited StatesUnited States Food and Drug Administration